NEW JERSEY — Patients For Affordable Drugs Now kicks off a campaign today thanking Reps. Andy Kim (NJ-03), Tom Malinowski (NJ-07), and Mikie Sherrill (NJ-11) for supporting Medicare negotiation, and calling on Rep. Josh Gottheimer (NJ-05) to support swift passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate lower prices for New Jerseyans. The campaign includes TV and digital ads as well as grassroots advocacy for constituents to contact the members in support of H.R. 3. The campaign comes after Big Pharma launched ads loaded with lies, attacking members for supporting the bill.

“New Jerseyans need Rep. Gottheimer to follow Reps. Kim, Malinowski, and Sherrill’s lead and push for passage of H.R. 3 to ensure we get affordable medicines we need now and innovation for the future,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “The choice is clear: You either stand with patients for lower prices or with pharma for higher prices. We need lower drug prices now.” 

The campaign includes TV and digital ads highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes, and thanking Reps. Kim, Malinowski, and Sherrill for supporting Medicare negotiation. The ads will run on a combination of TV and digital platforms within NJ-03, NJ-07, and NJ-11. 

“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”

You can watch the ad in NJ-03 here. 
You can watch the ad in NJ-07 here.
You can watch the ad in NJ-11 here.

Digital ads will run in NJ-05, urging Rep. Gottheimer to stand with patients and push for passage of H.R. 3.

H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

The campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching simultaneously in 42 House districts across 22 states and in D.C. 

###